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Abstract
Background: Resistance exercise programs with high compliance are needed to counter impaired muscle and
mobility in older cancer survivors. To date outcomes have focused on older prostate cancer survivors, though more
heterogeneous groups of older survivors are in-need. The purpose of this exploratory pilot study is to examine
whether resistance exercise via negative eccentrically-induced work (RENEW) improves muscle and mobility in a
diverse sample of older cancer survivors.
Methods: A total of 40 individuals (25 female, 15 male) with a mean age of 74 (± 6) years who have survived
(8.4 ± 8 years) since their cancer diagnosis (breast, prostate, colorectal and lymphoma) were assigned to a RENEW
group or a non-exercise Usual-care group. RENEW was performed for 12 weeks and measures of muscle size,
strength, power and mobility were made pre and post training.
Results: RENEW induced increases in quadriceps lean tissue average cross sectional area (Pre: 43.2 ± 10.8 cm
2; Post:
44.9 ± 10.9 cm
2), knee extension peak strength (Pre: 248.3 ± 10.8 N; Post: 275.4 ± 10.9 N), leg extension muscle
power (Pre: 198.2 ± 74.7 W; Post 255.5 ± 87.3 W), six minute walk distance (Pre: 417.2 ± 127.1 m; Post 466.9 ±
125.1 m) and a decrease on the time to safely descend stairs (Pre: 6.8 ± 4.5 s; Post 5.4 ± 2.5 s). A significant (P <
0.05) group x time interaction was noted for the muscle size and mobility improvements.
Conclusions: This exploration of RENEW in a heterogeneous cohort of older cancer survivors demonstrates
increases in muscle size, strength and power along with improved mobility. The efficacy of a high-force, low
perceived exertion exercise suggests RENEW may be suited to older individuals who are survivors of cancer.
Trial Registration: ClinicalTrials.gov Identifier: NCT00335491
Background
Maintaining an at-risk older individual’s mobility and
function is a top priority in aging research [1]. Older
cancer survivors represent an exemplar and needy target
group because cancer and its treatment are associated
with accelerated functional decline [2]; due, in part, to
low physical activity levels [3] and deficits in muscle and
mobility [4,5].
Only 1/5
th of older cancer survivors engage in exercise
consistent with public health recommendations despite
reports that exercise can improve fatigue levels [6],
quality of life [7], and strength [8], all predictors of con-
tinuing to exercise at recommended levels [9]. More-
over, the older cancer survivor’s admitted muscle
weakness limits their functional mobility (e.g., prolonged
walking and stair climbing) [3-5]. For this reason, resis-
tance exercise is the optimal mode of exercise to coun-
ter impaired mobility and the muscular side effects of
cancer such as muscle wasting and weakness. Addition-
ally, a high-intensity resistance exercise program is ideal
a st h ep o s i t i v ee f f e c t so nm u s c l es t r e n g t h ,c a r d i o p u l -
monary function, quality of life, and fatigue effects can
be maintained for at least one year [10].
A recent systematic review [8] of resistance exercise in
cancer survivors identified only two (out of 24) studies
dedicated solely to resistance exercise in older (65 years
* Correspondence: paul.lastayo@health.utah.edu
1Department of Physical Therapy, University of Utah, Salt Lake City, Utah,
USA
Full list of author information is available at the end of the article
LaStayo et al. BMC Geriatrics 2011, 11:5
http://www.biomedcentral.com/1471-2318/11/5
© 2011 LaStayo et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.of age or older) survivors. Segal [11] implemented a
supervised program (3 times per week for 12 weeks)
with older (mean age = 68 years) survivors and demon-
strated improvements in muscle strength in men on
androgen deprivation therapy following prostate cancer
versus a control group. In a subsequent study, Segal
[12] noted 24 weeks of resistance training in an identical
group improved quality of life, levels of fatigue, aerobic
fitness and strength. While accumulating evidence sup-
ports the efficacy of resistance training, many older can-
cer survivors who avoid or are unable to perform
resistance exercise will experience an accelerated func-
tional decline as muscle and mobility deficits constitute
the most influential risk factors for accidental falls in
older populations with chronic conditions [13]. Unfortu-
nately, the older cancer survivor has numerous barriers
to exercise that ultimately interfere with improved func-
tion [6], hence exercise modes with high participation
rates that focus on muscle strengthening and improved
mobility are a high priority.
A high-intensity resistance exercise via negative,
eccentrically-induced work (RENEW) program is safe
and feasible for older individuals, including prostate sur-
vivors [14], and can promote positive clinical changes in
muscle [15] and mobility [16,17]. Its efficacy, however,
has not yet been demonstrated in an older diverse
cohort of cancer survivors. The novelty of RENEW as a
potential physical exercise countermeasure for older can-
cer survivors is that only low levels of exertion are
required to produce relatively high (~2-4-fold greater)
muscle workloads and commensurate positive changes in
muscle and mobility [15,18]. This benefit may be espe-
cially important for older individuals who have limited
energy to put towards exercise due to the combination of
aging and long-term functional decline associated with
having survived cancer and its treatment.
We therefore conducted an exploratory pilot study to
examine whether RENEW improves muscle and mobility
in a diverse sample of older cancer survivors. We hypothe-
sized that RENEW would induce improvements following
the intervention period while those following a course of
usual-care would not demonstrate improvements.
Methods
The study was approved by the Institutional Review
Board at the University of Utah and was in accordance
with the Declaration of Helsinki. All participants pro-
vided written informed consent prior to participation.
We used a restricted randomization design to ensure a
balanced allocation into the arms of the study. This
exploratory pilot study took place in an academic health
science center setting. Participants were allocated to a
RENEW intervention or a usual-care control group
(Usual-Care) after using randomized blocks of varying
length (2 and 4), to approximate balance between treat-
ment arms. Sealed group assignment envelopes were
opened after screening and consent were completed.
Because this was an exploratory pilot study and it was
important to have adequate numbers in each group,
after a dropout the next group assignment was to that
respective group as a replacement. Outcome measures
were assessed by study personnel blinded to group
assignment at baseline and at the end of the interven-
tion period (12 weeks).
Recruitment and Eligibility
We employed a two-part approach to recruitment from
2006-2008 which included receiving names and identify-
ing information from: 1) clinical databases at the Uni-
versity of Utah and Huntsman Cancer Institute, and
2) individuals responding to announcements in a Salt
Lake City daily newspaper, or via word of mouth refer-
ral. This exploratory pilot study was designed to recruit
a sample of 40 cancer survivors, 20 participants rando-
mized to each group (RENEW and Usual-Care). The a
priori sample size calculation needed to detect a treat-
ment effect, defined as the difference in change scores
in the muscle and mobility variables between the
RENEW and usual care groups, with 90% power and an
alpha level of 0.05 was 18 participants per group. The
clinical database at the Huntsman Cancer Institute and
the data warehouse at the University of Utah hospitals
and clinics resulted in a pool of over 3000 patients from
which we identified 286 cancer survivors who met the
eligibility criteria related to age, diagnosis, and disease
status. Each of these potential participants received a
personal letter providing information about the study
and a prompt to return a postcard to the study coordi-
nator denoting no further contact be made regarding
potential participation; 19% exercised this opt-out
option. The 93 individuals responding to announce-
ments were contacted directly via phone to assess their
interest and screen for eligibility. All community ambulat-
ing males and females 60 years of age or older surviving
cancer (breast, prostate, colorectal, lung or lymphoma),
with no evidence of disease, and at least 6 months post-
treatment (local = surgery and/or radiation; or systemic
= chemotherapy; or a combination of local and systemic),
and a Folstein Mini-Mental State Examination score > 23
were eligible. Participants were included if they had mod-
erate levels (≥4 on a scale from 0-10) of fatigue and/or
weakness as measured by the General Fatigue Scale and
General Weakness Scale respectively. Those who met
inclusion and were enrolled in the study also provided a
list of comorbidities and their level of health related qual-
ity of life via a structured interview process and comple-
tion of the Short-Form 36 questionnaire respectively.
Individuals were excluded if they had a central nervous
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ease), neurological insult (e.g., cerebrovascular accident),
chronic fatigue syndrome, or myopathic or rheumatologi-
cal disease that adversely impacts skeletal muscle struc-
ture/function or manifests in a mobility disorder.
Engaging in regular (2-3 times per week) exercise (aerobic
or resistance) during the preceding 6 months constituted
another reason for exclusion.
RENEW Intervention
The lower extremity RENEW exercise occurred on a
recumbent eccentric stepper with a focus on the knee
extensor (quadriceps) muscle group as previous studies
[15-17] have noted clinically beneficial changes in the
quadriceps with RENEW and positive relationships
between quadriceps function and mobility in older indivi-
duals [16]. An exercise specialist in a health science cen-
ter-clinical setting supervised each participant’se x e r c i s e
session. Prior to training, the stepper seat setting was
individually adjusted to each participant’s leg length, and
safety guidelines were reviewed. The recumbent eccentric
stepper was powered by a 2-hp motor that drives the foot
pedals in a “backward” direction (i.e., toward the indivi-
dual). Eccentric muscle contractions occurred when the
participant attempted to resist this motion by pushing on
the pedals (with verbal instruction to “try to slow down
the pedals”) as the pedals moved toward the participant.
Because the magnitude of the force produced by the step-
per exceeded that of the participant’s, the pedals contin-
ued to move toward the participant at a constant velocity
(15-20 cycles per minute), resulting in eccentric contrac-
tions of the knee and hip extensors, including the quadri-
ceps muscles (Figure 1).
The subjects began with thrice weekly, 3-5 minute ses-
sions on the stepper for the first 2 weeks and progressed
to a maximum of 15 minutes over the next 3 to 4 weeks
and attempts were made to perform RENEW on the
stepper for 16-20 minutes for the last 8 weeks. The pro-
gression of the eccentric exercise work rate was deter-
mined as a function of the perceived exertion (RPE)
using a “target” workload on a computer monitor and is
summarized in Table 1. Once the subjects achieved an
RPE of “somewhat hard,” they were instructed to main-
tain that RPE for the duration of the exercise program.
Usual-Care
The Usual-Care group did not participate in the
RENEW exercise program, but continued with their
oncology follow-up care. Since the participants were
cancer survivors this generally included a recommenda-
tion to call their oncologist or primary health care pro-
vider if any symptoms became problematic. Follow-up
oncology appointments were at 6-month intervals and
moved to annual visits after a year or two of continued
remission.
Measures
Muscle Size: Quadriceps Lean Tissue
Muscle size (cm
2), i.e., the average mid-thigh cross-sec-
tional area (CSA) of lean skeletal muscle tissue of the
quadriceps was determined using magnetic resonance
image (MRI) of both thighs. Participants were placed
s u p i n ei na1 . 5T e s l aw h o l eb o d yM Ri m a g e r( S i g n a
Lightening LX 8.4; General Electric Medical Systems,
Milwaukee, WI). To establish the region of interest
(ROI), a coronal fast spoiled gradient echo scout scan
was used to identify the superior and inferior boundaries
of the scans (the femoral head and the tibiofemoral joint
line). Once the ROI was established, axial T1 weighted
images were acquired in the standard body coil using a
fast-spin echo sequence with repetition time/time to
echo = 550/9.2, 8-mm slice thickness, 15-mm interslice
distance, and a 320 X 320 matrix. Four images from the
middle 1/3 of each thigh were used to determine aver-
age CSA of lean tissue using custom written image ana-
lysis software (MatLab; Mathworks, Natick, MA).
Manual tracing eliminated subcutaneous fat and bone
and isolated the fascial border of the thigh to create a
subfascial ROI. The total number of pixels within the
ROI, a frequency distribution and a histogram of all pix-
els and signal intensities produced a specific peak desig-
nated as lean tissue. The same investigator, blinded to
time point of the scan and slice location, performed
measurements of individual participants before and after
training. This technique has demonstrated high levels of
intrarater reliability with an average interclass correla-
tion coefficient of 0.99 and the validity of the measure-
ment was determined by analysis of images obtained
from a cadaveric thigh phantom [16].
Muscle Strength: Maximal Voluntary Isometric Knee
Extension Peak Force
Knee extension peak strength (N) was quantitatively
assessed by unilateral maximal voluntary isometric
efforts on a KinCom dynamometer (Chattanooga Inc.,
Hixon, TN.). Both lower extremities were tested and
these strength measures were assessed prior to and two-
five days following the training interventions. Partici-
pants were seated and their knees were fixed at 90° of
flexion and they were stabilized by chest and thigh
straps. Participants were asked to fold their arms across
their chest while performing these tests. Prior to testing,
participants practiced submaximal contractions at 50%
and 75% of their maximal effort. Three practice trials
were then performed. After a brief rest period, three
separate maximal contractions were performed, each
held for 5 seconds with a 3-minute rest between trials.
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calculated as the average of both lower extremity peak
f o r c et r i a l s .T h et e s to fi s o metric knee extension peak
force with an isokinetic dynamometer machine has
excellent reliability with ICCs > 0.99 [19].
Muscle Power: Stair Climbing Leg Power
Leg extension muscle power (W) was assessed with a
simple, clinically-utilized timed stair climb power test
[20]. Stair climb leg muscle power was calculated with
the following formula: power equals force times velocity.
Stair climb time (s) and vertical height of the stairs (m)
were used to calculate velocity (distance/time), and body
mass (kg) and acceleration (m/s
2) due to gravity were
used to calculate force. At the base of a well-lighted,
10-stair flight participants were instructed to safely
ascend the stairs as fast as they could when the exami-
ner said, “Ready, set, go.” Timing began once the partici-
pant began moving. When both feet of a participant
reached the top step, the timing stopped. Time was
recorded to the nearest 0.01 s, and the average of 3
trials was taken. The stair climb power measure is clini-
cally relevant as it is associated with more complex
modes of testing leg power impairments in older indivi-
duals (20) and the test-retest reliability is excellent with
ICCs > 0.94 [21].
Mobility: Six-Minute Walk and Stair Descent Tests
The six-minute walk test, an assessment of mobility
used to assess overall locomotion and endurance, mea-
sures the distance (m) walked in six minutes. Partici-
pants were asked to cover as much distance as possible
within six minutes without running. The six-minute
walk test has high test-retest reliability in older popula-
tions with various co-morbid conditions [22,23].
The stair descent test of mobility relies almost exclu-
sively on eccentric muscle contractions. Since mobility
tasks requiring graded eccentric contractions are com-
promised more in old individuals than is the ability to
perform concentric contractions while ascending stairs,
impaired eccentric control may contribute to the
greater number of falls during stair descent. Therefore,
we employed the stair descent test of mobility by ask-
ing participants to descend one flight of stairs under
close or contact supervision as quickly and safely as
possible. Time was recorded to the nearest 0.01 second
from a verbal go signal to final foot placement on a
standard flight of 10 stairs and the average of three
trials was recorded. Previous research has supported
the high reliability of this measure of mobility with
ICCs > 0.97 [24].
Figure 1 High muscle forces are generated on an eccentric stepper (Eccentron; BTE Technologies, Inc., Hanover, MD, USA) powered
by a 2-horsepower motor that drives the pedals. As the pedals move toward the participant (largest arrow), the rider resists by applying
force to the pedals (arrow at foot level). Because the magnitude of force produced by the motor exceeds that produced by the rider, the leg
extensors (arrows in thigh) work eccentrically (lengthening), creating negative work.
Table 1 Perceived Exertion and RENEW Progression: The
frequency and duration of RENEW and the rating of
perceived exertion over the 12 Week Training Period
Week Times/
Week
Training
Duration
Rating of Perceived Exertion
1 3 3-5 minutes 7 (very, very light)
2 3 5 minutes 9 (very light)
3 3 6-10 minutes 11 (fairly light)
4 3 11-15 minutes 11-13 (fairly light to somewhat
hard)
5-12 3 16-20 minutes 11-13 (fairly light to somewhat
hard)
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Data were analyzed with Sigma Stat Version 3.5
(Chicago, IL). Descriptive statistics were calculated for
demographic variables and dependent measures. The
assumptions of parametric statistical tests were assessed
via tests of normality and homogeneity of variance. In
all cases, the assumptions were met and therefore para-
metric tests were performed. In the analyses, we evalu-
ated the effect of RENEW and Usual Care on muscle
size, strength, power and mobility. First, pre-intervention
baseline values for the dependent variables for RENEW
and the Usual-Care groups were compared and tested
with independent sample t-tests. Next, in order to con-
trol for potential pre-intervention differences between
the groups, the primary aim was examined with a 2-way
repeated-measures analysis of covariance (ANCOVA),
with group (RENEW versus Usual-Care) as the between-
subjects variable and time (Pre and Post intervention)
as the within subject variable for each dependent vari-
able: muscle size, strength, power and mobility. In all
cases, the pre-intervention value for each dependent
variable was used as the covariate. Because our hypoth-
eses were focused on the differential response of the
groups, our primary interest was the interaction
between the group x time effects. In order to fully
understand what changes drove any observed interac-
tion effects or time main effects, and to examine and
compare the magnitude of within group changes, inter-
val estimators of pre to post intervention differences
(95% confidence intervals of the mean differences) as
well as calculation of within group effect sizes (ES) were
utilized. The level of statistical significance for all tests
for differences was set at p < 0.05.
Results
Participants
The participants included a total of 40 individuals (25
female, 15 male) with a mean age of 74 (± 6) years and
ab o d ym a s si n d e xo f2 8( ±6 )( t a b l e2 ) .T h ec o h o r t s
mean survival was 8.4 (± 8) years since their cancer
diagnosis. Additionally, a description of all participants’
baseline levels of fatigue and weakness, and their health
related quality of life, are depicted in table 2.
The prevalence of cancer types, comorbid disease
conditions and cancer treatments amongst the cohorts
is depicted in table 3; breast = 55%, prostate = 28%,
colorectal = 18%, lung = 5%, and lymphoma = 3%.
Arthritis and hypertension were the most frequently
listed comorbidities amongst the participants. The par-
ticipants’ previous treatment for their cancer(s) was
characterized as either a local treatment (surgery ±
radiation therapy) = 70%, a systemic treatment (che-
motherapy) = 10%, or a combination of a local and
systemic treatment = 20%.
The restricted randomization design ensured age and
sex balance between treatment groups and resulted in 20
individuals per group being analyzed. See the Consolidated
Standards of Reporting Trials (CONSORT) diagram
(Figure 2). Following the restricted randomization, 28 indi-
viduals were assigned to the RENEW group and 21 indivi-
duals to the Usual-Care group. Following the dropout of
individuals during the allotted intervention period (n = 7
from the RENEW group) or post-testing period (n = 1
from the RENEW group) the next group assignment was
to that respective group as a replacement. There were no
Table 2 Characteristics of the 40 participants randomized
into the RENEW (females n = 13, males n = 7) and Usual-
Care (females n = 12, males n = 8) groups: The mean and
standard deviation (SD) of: age, survival in years, body
mass index, self-reported levels of fatigue and weakness
from the General Fatigue Scale and General Weakness
Scale respectively, and the physical and mental health-
related quality of life (HRQOL) from the Short Form-36
RENEW Usual-Care
Age in Years 75 (7) 73 (5)
Survival in Years 8.5 (9) 8.3 (7)
Body Mass Index 28 (4) 29 (7)
Self Report of Fatigue on 0-10 scale 4.8 (1.7) 4.9 (2.1)
Self Report of Weakness on 0-10 scale 4.2 (1.7) 4.4 (2.1)
Physical-HRQOL 42 (9) 39 (10)
Mental-HRQOL 56 (4) 51 (15)
Table 3 The absolute number and relative (%) prevalence
of cancer types, comorbid disease conditions and cancer
treatments amongst the cohorts
RENEW Usual-Care
Cancer Type
Breast 10 (50%) 12 (60%)
Prostate 4 (20%) 7 (35%)
Colorectal 4 (20%) 3 (15%)
Lymphoma 1 (5%) 0 (0%)
Lung 1 (5%) 2 (10%)
Comorbidities
Arthritis 14 (29%) 12 (29%)
Hypertension 13 (27%) 10 (24%)
Heart Disease 5 (10%) 6 (15%)
Lung Disease 5 (10%) 5 (12%)
Gastric Ulcers 3 (6%) 4 (10%)
Diabetes 4 (8%) 2 (5%)
Stroke or TIA 2 (4%) 1 (2%)
Kidney Disease 2 (4%) 1 (2%)
Neuromuscular 1 (2%) 0 (0%)
Cancer Treatment
Local 14 (70%) 13 (65%)
Systemic 2 (10%) 2 (10%)
Local and Systemic 4 (20%) 5 (25%)
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who did not complete RENEW dropped out due to ill-
nesses not thought to be associated with participating in
the study (n = 5) or scheduling conflicts (n = 2).
The 21 participants in the RENEW group completed an
average of 34 out of the potential 36 sessions over 12
weeks of RENEW, resulting in a compliance rate of 95%.
The total average RENEW per week increased over the
12 weeks of training. Following the first 2 weeks of
acclimatization and ramping up of RENEW in a progres-
sive fashion, participants increased their workload ~3-
fold from week 3 (7.6 ± 5.1 kJ) to week 12 (22.1 ± 14.8
kJ).
Measures
Muscle Size: Quadriceps Lean Tissue
The pre-intervention and post-intervention group mean
values and within-group mean change scores (and 95%
Clinical Databases
n=286
Newspaper Announcements 
and Referrals
n=93
Allocated to RENEW n=28
Received allocation n=20
Did not receive allocation n=7
(5 illness, 2 schedule conflict)
Enrolled
n=24
Excluded n=261
Inelligible n= 19
Elligible but not confirmed n=66
Not interested n=52
Too far to commute n=6
Too busy n=9
Cancelled screening n=4
Deceased n=4
Other medical issues n=3
Postcard refusal n=53
Incorrect address n=4
Unable to reach n=41
Excluded n=69
Inelligible n=24
Elligible but not confirmed n=21
Not interested n=12
Too far to commute n=4
Too busy n=6
Cancelled screening n=2
Enrolled
n=25
Lost to follow-up 
n=1
(death)
Lost to follow-up
n=1
(schedule conflict)
Analyzed n=20
Excluded n=1
Analyzed n=20
Excluded n=8
Allocation
Follow-up
Analysis
Total Enrollment n=49
Allocated to Usual Care  n=21
Received allocation n=21
Figure 2 The consolidated standards of reporting trials (CONSORT) diagram for the study.
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table 4. Significant (p < 0.05) pre-intervention differ-
ences existed between groups for quadriceps lean tissue
average cross sectional area (RENEW: 43.2 ± 10.8 cm
2;
Usual-Care: 50.9 ± 11.4 cm
2). The post-intervention
quadriceps lean tissue average cross sectional area
(RENEW: 44.9 ± 10.9 cm
2; Usual-Care: 50.8 ± 11.7 cm
2)
changes resulted in a statistically significant (p = 0.001)
group x time interaction effect for muscle size. The
magnitude of change in the RENEW group (4% increase,
ES = .16) was greater than the Usual-Care group’s pre to
post intervention difference. (<1% increase, ES = .01).
Muscle Strength: Maximal Voluntary Isometric Knee
Extension Peak Force
The pre-intervention and post-intervention group mean
values and within-group mean change scores (and 95%
confidence intervals) for muscle strength, are depicted
in table 4. There were no significant (p > 0.05) pre-
intervention maximal voluntary knee extension peak
force differences between groups (RENEW: 248.3 ± 92.2 N;
Usual-Care: 268.0 ± 73.6 N). The post-intervention maxi-
mal voluntary knee extension peak force (RENEW: 275.4 ±
99.3 N; Usual-Care: 271.0 ± 75.0 N) changes did not result
in a statistically significant (p = 0.15) group x time interac-
tion effect for muscle strength. However, the magnitude of
change in the RENEW group, (11% increase, ES = .28)
exceeded the Usual-Care group’s pre- to post-intervention
(1% increase, ES = .04).
Muscle Power: Stair Climbing Leg Power
The pre-intervention and post-intervention group mean
values and within-group mean change scores (and 95%
confidence intervals) for muscle power, are depicted in
table 4. There were no significant (p > 0.05) pre-inter-
vention stair climbing leg power differences between
groups (RENEW: 198.2 ± 74.7 W; Usual-Care: 239.6 ±
82.2 W). The post-intervention stair climbing leg power
(RENEW: 255.5 ± 87.3 W; Usual-Care: 258.4 ± 94.4 W)
changes resulted in a statistically significant (p = 0.04)
group x time interaction effect for muscle power. The
magnitude of change in the RENEW group (29%
increase, ES = .71) was greater than the Usual-Care
group’s pre- to post intervention difference (8% increase,
ES = .21).
Mobility: Six-Minute Walk and Stair Descent Tests
The pre-intervention and post-intervention group mean
values and within-group mean change scores (and 95%
confidence intervals) for mobility, are depicted in table
4. There were no significant (p > 0.05) pre-intervention
six-minute walk and stair descent test differences
between groups (RENEW: 417.2 ± 127.1 m; Usual-Care:
442.7 ± 101.9 m; and RENEW: 6.8 ± 4.5 s; Usual-Care:
5.8 ± 2.4 s). The post-intervention six-minute walk dis-
tance (RENEW: 466.9 ± 125.1 m; Usual-Care: 453.1 ±
121.9 m) changes resulted in a statistically significant
(p = 0.03) group x time interaction effect for mobility. The
magnitude of the RENEW group change (12% increase, ES
= .39) was greater than the Usual-Care group’sp r e -t o
post intervention difference (2% increase, ES = .09).
The post-intervention stair descent time (RENEW: 5.4 ±
2.5 s; Usual-Care: 5.5 ± 1.9 s) changes did not result in a
statistically significant (p = 0.07) group x time interaction
effect for mobility. However, the magnitude of the
RENEW group’s change (21%, ES = .40) exceeded the
Usual-Care group’s pre to post intervention difference
(5%, ES = .14).
Discussion
The overarching finding from this exploratory pilot
study is that an older, heterogeneous group of cancer
survivors can improve their muscle and mobility status
with a unique form of resistance training; and that com-
pliance is excellent with 12 weeks of the RENEW inter-
vention. Collectively these outcomes have a high clinical
impact considering the priority placed on mitigating
Table 4 Group (RENEW and Usual Care) pre and post intervention mean values, within group mean change scores
(95% CI) and effect size, and the ANCOVA group by time interaction F-score and p-value for the muscle size, muscle
strength, muscle power and mobility outcomes
RENEW Usual Care
Pre Post Change (95% CI) and
Effect Size (ES)
Interaction Group x Time
F Score (p value)
Pre
Mean
Post
Mean
Change (95% CI) and
Effect Size (ES)
Quadriceps Lean Tissue Average
Cross Sectional Area (cm
2)
43.2 44.9 1.7 (1.1 to 2.3)
ES = 0.16
14.5 (0.001)† 50.9 50.8 -0.1 (-0.8 to 0.6)
ES = 0.01
Knee Extension Peak Strength (N) 248.3 275.4 27.1 (4.5 to 49.7)
ES = 0.28
1.8 (0.19) 268.0 271 3.0 (-22.3 to 28.3)
ES = 0.04
Leg Extension Muscle Power (W) 198.2 255.5 57.3 (24.4 to 90.2)
ES = 0.71
3.6 (0.07) 239.3 258.4 19.1 (0.8 to 37.6)
ES = 0.22
Six Minute Walk (m) 417.2 466.9 49.7 (26.0 to 73.4)
ES = 0.39
5.0 (0.03)† 442.7 453.1 10.4 (-15.9 to 36.7)
ES = 0.09
Stair Descent (s) 6.8 5.4 1.4 (0.5 to 2.4)
ES = 0.40
4.7 (0.04)† 5.8 5.5 0.3 (-0.2 to 0.8)
ES = 0.14
† = Significant (p < 0.05) group by time interaction via an ANCOVA.
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[25] and that previous resistance exercise studies with
older (>59 years of age) individuals have been limited to
survivors of prostate cancer [11,12,26].
Cancer and its treatment typically induces muscle
atrophy due to perturbations in muscle protein metabo-
lism, including decreased muscle protein synthesis,
increased muscle protein degradation, or a combination
of both [27]. Therefore, the modest, but resultant
increase (4%) in quadriceps lean tissue cross sectional
area following RENEW is promising especially because
previous resistance exercise trails with cancer survivors
[8] have not demonstrated evidence of an effect on leg
lean tissue cross sectional area in older cancer survivors,
and a similar effect of RENEW has been noted with
older prostate cancer survivors [14]. The increase (11%)
in knee extension peak strength following RENEW is
also favorable particularly when coupled with the large
effect and increase (29%) in leg extension muscle power.
Previous resistance exercise trials in cancer survivors
reveal overall upper and lower body strength increases
following resistance training, though very few studies
[14] testing knee extension strength have demonstrated
a positive effect [8]. Segal demonstrated a greater
increase in lower body strength in survivors of prostate
cancer following 12 [11] and 24 [12] weeks of supervised
resistance training, though the participants were
younger than our cohort and composed of men-only.
Likewise, prostate cancer survivors from another study
[26] improved their leg press strength over 90% after
20 weeks of resistance exercise, though this may be an
overestimate as the mode of testing was identical to
the resistance exercise mode. Finally, the large effect
of RENEW on improving leg muscle power, a hereto-
fore unreported outcome in older cancer survivors,
may be the most significant muscle outcome since
muscle power production is more closely related to
mobility in older individuals than either muscle size
or strength [28].
The improved mobility status following RENEW is a
critical outcome as physical function is characterized in
l a r g ep a r tb yt h ea b i l i t yt om o v ea b o u t ,a n dm o b i l i t y
impairments are targeted by rehabilitation interventions
in needy older populations like cancer survivors. After
12 weeks of RENEW a 12% increase in walking endur-
ance resulted, which exceeds the 7% increase reported
by Galvao [26] after 20 weeks of resistance exercise in
older prostate cancer survivors. Notably, we also
observed a 21% improvement in the ability to descend
stairs safely following RENEW. This is a critical task
since a preponderance of falls occur while negotiating
stairs, especially during stair descent [29]. The improved
mobility status in older cancer survivors following
R E N E Wi sc o m m e n s u r a t ew i t hp r e v i o u s l yr e p o r t e d
improvements in mobility in other older populations
[14-17].
The first exercise study that targeted older cancer sur-
vivors by Denmark-Wahnefried et al [30] reported that
when public health guidelines for vigorous exercise were
met higher scores on physical functioning resulted.
Unfortunately, adherence to exercise is the lowest
(<65%) for the oldest cancer survivors enrolled in clini-
cal trials [31]. Because RENEW requires only “somewhat
hard” levels of perceived exertion to induce positive
muscle and mobility responses in 70+ year old cancer
survivors, it may be a reason for its excellent compliance
rate (95%) which exceeds that of younger (<65 years of
age) cancer survivors [32]. The most recent exercise
study that targeted older cancer survivors by Morey
et al [33] included a heterogeneous cohort that was
nearly identical to ours and consisted of 70+ year old
males and females who were 8-9 year survivors of breast,
prostate and colorectal cancers. Those who exercised in
this study experienced a less rapid deterioration of physi-
cal function over a one-year period after following a
home-based diet and exercise regimen. In our study a
supervised RENEW program followed for less than one-
f o u r t ho ft h et i m e( 1 2w e e k s )r e v e r s e daf u n c t i o n a l
decline rather than simply ameliorated a functional
decline. This reversal of deficits in physical function has
been documented following RENEW in other older
populations [14-17].
This study of RENEW with older cancer survivors fills
a void in the resistance exercise literature as a lack of
information regarding the optimal type, intensity, and
duration of physical exercise exists [34]. There are, how-
ever, limitations to this exploratory trail therefore the
results should be interpreted with caution. This study
was exploratory in nature and utilized a restricted ran-
domization approach to achieve balance in size between
the groups and to have adequate experience with the
intervention and enough participants for comparison.
A future randomized clinical trial is needed to substanti-
ate the findings. Further, the heterogeneous cohort of
males and females who have survived various cancer
types and treatments prevents a generalization of the
results to specific subgroups of cancer survivors. This
heterogeneity, however, represents the diversity of older
individuals who have survived cancer and who are lim-
ited in both their muscle and mobility status and hence
are in need of rehabilitation countermeasures. Likewise,
this exploratory trial’s lack of control of attention, phy-
sical activity levels and general health related behaviors
during the intervention period may confound the
results. The RENEW intervention’s effect, however, was
robust enough to withstand inherent variability amongst
the cohorts and lack of control of potentially confound-
ing variables. Overall, we believe the results represent a
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RENEW for older cancer survivors, due to the relatively
small sample size, a larger trial with an intent to treat
approach is needed to determine RENEW’so v e r a l l
effectiveness.
Conclusions
This exploration of RENEW in a heterogeneous cohort
of older cancer survivors demonstrates increases in mus-
cle size, strength and power along with improved
mobility.
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